Company, the leading business intelligence provider, has released its latest research Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure”.
Aarkstore.com announces, The Latest market research report is available in its vast collection: Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure http://www.aarkstore.com/reports/Pricing-and-Reimbursement-of-the- Healthcare-System-in-India-Low-Levels-of-Drug-Reimbursement-Lead-to-a- High-Out-Of-Pocket-Expenditure-194956.html RSS Link of GBI Research Company announces 15% discount on this report. Discount till 30th June 2012 Summary Company, the leading business intelligence provider, has released its latest research Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure”. It provides a comprehensive overview of the healthcare system, and pricing and reimbursement process in India with a detailed analysis of the different regulatory mechanisms used in India. The report closely scrutinizes the major changes in pharmaceuticals related pricing and reimbursement in the recent past, and the impact these changes will have in the future. The health insurance is responsible for facilitating demand by making high-cost prescription drugs more affordable. Although the per capita income is rising in India, the modest income of most of the population keeps the high cost drugs and medicines out of reach of the majority of the population. Scope - Detailed study of the healthcare systems and roles of the key insurance players in the drug reimbursement process - Analysis of the major pricing and reimbursement mechanisms in India. - Key trends that follow from the recent changes brought about in the pricing and reimbursement mechanism. - Build an understanding of the possible major challenges brought about by the enactment of changes in the pricing and reimbursement scene in India. Table of contents: 1.1 List of Tables 5 1.2 List of Figures 5 2 Pricing and Reimbursement in India - Introduction 6 2.1 GBI Research Report Guidance 6 3 Pricing and Reimbursement in India - Overview 7 3.1 Introduction to Healthcare System in India 7 3.1.1 Healthcare Expenditure Highly Correlated with GDP 7 3.1.2 Estimated Public Health Spending as a Percentage of GDP 9 3.1.3 Health Expenditure per Capita 9 3.1.4 Out-of-Pocket Health Expenditure as a Percentage of Private Expenditure on Health 10 3.1.5 Demographics by Age 10 3.2 Public Healthcare System 11 3.2.1 Drug Distribution in the Public Sector 12 3.3 Private Healthcare System 12 3.4 Rationale for Drug Use in the Healthcare Facilities 13 4 Pricing and Reimbursement in India- Overview of Pharmaceutical Regulations in India 14 4.1 PEST Analysis of the Pharmaceutical Industry in India 14 4.2 Regulatory Bodies in the Indian Pharmaceutical Sector 15 4.2.1 National Pharmaceutical Pricing Authority (NPPA) 15 4.2.2 Drug Prices Control Order (DPCO) 16 4.2.3 The Pharmaceutical Policy, 2002 16 5 Pricing and Reimbursement in India- Pricing of Drugs 17 List of Figures List of Tables are also include. For more DISCOUNT related Reports Plz follow The link: Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced Potential Risk of Hypoglycemia to Increase the Market Share of DPP-IV Inhibitors and GLP-1 Agonists Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform Plans Forecast to Slow Growth Rates Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients Pediatric Vaccines Market to 2017- Strategic Focus on Partnering as Licensing and Co-Development Accounted for 69% of Deal-Making Activity from 2004-2011 Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion Neurometabolic Disorders Market to 2017 - Novel Therapies for Rare Diseases such as Gaucher’s and Niemann-Pick Poised to Supersede Existing Therapies Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future Transcatheter Heart Valve Market to 2017 - Improvements in Design and Technique and a Favorable Reimbursement Scenario to Contribute to Higher Procedure Volumes Smart Grid Market in Europe to 2020 - Advanced Grid Concepts and Intelligent Technology Pivotal to Achieving EU 20-20-20 Targets Oil and Gas Storage Industry to 2015 - Cost Reduction Strategies in the Form of Storage Facility Sharing to Boost the Market You can also request for sample page of above mention reports on email@example.com For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: firstname.lastname@example.org
Pages to are hidden for
"Aarkstore.com 2012 15% Discount ||"Please download to view full document